TODD STRATEGY GROUP

Lobbying for TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Rare Disease Issues.

Medicare/Medicaid

General Medicare/Medicaid Issues. Implementation of Inflation Reduction Act of 2022.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.